doi:10.1056/NEJMcp1113996 2Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ
Some patients report spending weeks or months working through authorization processes, only to face denial and appeals
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, reveals that the medication suppresses signaling in the brains reward center thought to be involved in food noisebut only temporarily
Common overlapping side effects include nausea, vomiting, diarrhea, and abdominal discomfort
Of note, this BPC 157 effect may be indicative of its particular anti-glaucomatous effect
These were standardized to a weight of 239 kilocalories